Completed PHASE1 INTERVENTIONAL 1-arm NCT01950546

Nanosilver Fluoride to Prevent Dental Biofilms Growth (NSFCT)

Nanosilver Fluoride: a Microbiological and Clinical Trial

Sponsor: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Updated 5 times since 2017 Last updated: Jun 8, 2015 Started: Sep 30, 2014 Primary completion: Dec 31, 2014 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Dental Caries and is currently completed. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
University of Pernambuco

Data source: University of Pernambuco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• João Pessoa, Brazil